The Leadership Team at Trevi Therapeutics is responsible for setting the strategic direction and vision of the company, overseeing the development of nalbuphine ER, and guiding the organization through clinical trials and commercialization. Comprising experienced executives in science and finance, this team ensures alignment between clinical goals and business objectives while fostering innovation and collaboration to advance treatments for neurologically mediated conditions.
View all